---
title: Sonoelastography of the Supraspinatus Tendon
nct_id: NCT03425357
overall_status: COMPLETED
phase: NA
sponsor: Karen Brage
study_type: INTERVENTIONAL
primary_condition: Elasticity Imaging Techniques
countries: Denmark
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03425357.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03425357"
ct_last_update_post_date: 2019-08-22
last_seen_at: "2026-05-12T06:28:49.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Sonoelastography of the Supraspinatus Tendon

**Official Title:** Responsiveness of Sonoelastography in the Supraspinatus Tendon

**NCT ID:** [NCT03425357](https://clinicaltrials.gov/study/NCT03425357)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 23
- **Lead Sponsor:** Karen Brage
- **Collaborators:** Odense University Hospital, Sygehus Lillebaelt, Gigtforeningen, Region of Southern Denmark, Radiograf Rådet
- **Conditions:** Elasticity Imaging Techniques, Tendinopathy, Rotator Cuff Tendinitis, Musculoskeletal Disease
- **Start Date:** 2018-03-25
- **Completion Date:** 2019-08-21
- **CT.gov Last Update:** 2019-08-22

## Brief Summary

This study aims a determine the responsiveness of sonoelastography in the tendinopathy-affected supraspinatus tendon.

## Detailed Description

The trial will include 20 patients diagnosed with supraspinatus tendinopathy from one orthopaedic shoulder clinic in Denmark.

The intervention will consist of an exercise program including lowload exercises with elastics and dumbbells, targeting the rotator cuff in a 12 weeks home-exercise program with two control visits at a physiotherapy department at the hospitals.

Tissue elasticity (measured by sonoelastography) is used as the primary outcome and is measured 12 weeks post baseline

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 60 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Able to read and understand Danish
* Shoulder pain \> 3 months
* Positive on 3/5 clinical tests (full can, empty can, resisted external rotation, neers, hawking)
* Tendinopathy (MRI)

Exclusion Criteria:

* BMI \> 30
* Bilateral shoulder pain
* Supraspinatus full thickness rupture (US)
* Biceps rupture (US)
* Calcification in supraspinatus (X-ray)
* Pregnancy
* Glenohumeral arthrosis (X-ray)
* Frozen shoulder
* Shoulder symptoms originating from neck
* Shoulder fracture, operation or luxation
* Known neuromuscular disease, rheumatoid arthritis, cancer, fibromyalgia, spondylarthropathy or psychiatric disorders
* Labrum lesion (MRI)
* Tear (˃1/3 of supraspinatus, vertical height) (MRI)
```

## Arms

- **Low Load Exercises** (EXPERIMENTAL) — An exercise program consisting of 6 active exercises. Two exercises for the rotator cuff: Full Can and Sidelying external rotation Two exercises for the scapulae stabilizing muscles: Low Row and Push-Up Plus Two glenohumeral/postural corrective exercises: Posterior GH stretch and Scapular Retraction.

## Interventions

- **Low Load Exercises** (OTHER) — All rotator cuff and scapular exercises are performed with 3 sets of 20 repetitions 3 times per week for 12 weeks. The load is set at around 60% of 1 RM (20 reps).

The glenohumeral/postural corrective exercises are performed with 3 sets of 5 repetitions (The position is held for 15 seconds per repetition).

## Primary Outcomes

- **Tendon quality (SEL)** _(time frame: Baseline and 12 weeks)_ — Change from baseline in tendon quality (sonoelastography - strain elasticity)

## Secondary Outcomes

- **Tendon quality (MRI)** _(time frame: Baseline and 12 weeks)_
- **Tendon quality (US)** _(time frame: Baseline and 12 weeks)_
- **Strength** _(time frame: Baseline and 12 weeks)_
- **Recovery** _(time frame: 12 weeks)_
- **Pain** _(time frame: Baseline and 12 weeks)_

## Locations (1)

- University of Southern Denmark, Odense, Denmark

## Recent Field Changes (last 30 days)

- `results.hasResults` — added _(2026-05-12)_
- `locations.university of southern denmark|odense||denmark` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03425357.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03425357*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*